Trinity Biotech Plc Expands Capabilities with Benchmark Risk Group Acquisition
- Trinity Biotech enhances its capabilities by acquiring Benchmark Risk Group, focusing on exposure science and risk assessment.
- The acquisition strengthens Trinity's Risk Science and Safety business, expanding its service offerings in health risk management.
- Dr. Jennifer Pierce joins Trinity's leadership, supporting the integration of Benchmark's expertise for improved service delivery.
Trinity Biotech Expands Expertise with Benchmark Risk Group Acquisition
Trinity Consultants, a leading global firm in life sciences and environmental health and safety (EHS) regulatory compliance, enhances its capabilities through the recent acquisition of Benchmark Risk Group, announced on October 14, 2025. This strategic move targets the growing complexities of assessing chemical, physical, and biological exposures in various environments. Based in Chicago, Benchmark Risk Group brings a wealth of expertise in exposure science, industrial hygiene, and risk assessment, aligning seamlessly with Trinity’s mission to deliver rigorous and innovative solutions in health risk evaluation.
The acquisition marks a significant evolution in Trinity's service offerings, particularly in the Risk Science and Safety business line. Albert Dyrness, divisional president of Trinity Consultants Life Sciences, highlights Benchmark's commitment to scientific rigor as a perfect fit for Trinity's objectives. This integration allows Trinity to bolster its interdisciplinary team of science advisers, enhancing their ability to address multifaceted exposure scenarios. By leveraging Benchmark's specialized knowledge, Trinity aims to expand its portfolio of services, thereby solidifying its position as a leader in health risk management and safety consulting.
Dr. Jennifer Pierce, the president of Benchmark Risk Group, is set to join Trinity's leadership team, ensuring a continuity of high-quality scientific solutions that Benchmark has been known for. This acquisition occurs at a transformative time for Trinity, as the company streamlines its various life sciences divisions—including Advent Engineering Services, Aztec Technologies, SafeBridge Consultants, and Safety Partners—under a unified identity. This consolidation is expected to not only improve service delivery but also create new growth opportunities for the firm, enhancing Trinity's competitive edge in the evolving landscape of life sciences consulting.
In addition to enhancing its service capabilities, Trinity’s acquisition of Benchmark Risk Group underscores a broader trend within the life sciences industry, where integrated approaches to health risk management are increasingly vital. As regulatory frameworks continue to evolve and the demand for comprehensive safety solutions grows, Trinity positions itself to meet these challenges head-on, reinforcing its role in advancing public health initiatives.
As Trinity Consultants continues to expand and innovate, the integration of Benchmark's expertise represents a crucial step in addressing the intricate challenges of environmental health and safety, ensuring that the firm remains at the forefront of the industry. For further details about Trinity Consultants and its leadership initiatives, interested parties can visit their official website.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

